Previously we have described the derivation of three distinct classes of leukemic cell clones from a single in vivo-passaged myelomonocytic leukemia, , that arose in a mouse infected with the Abelson leukemia virus/Moloney leukemia virus complex (K. B. Leslie and J. W. Schrader, Mol. Cell. Biol. 9:2414Biol. 9: -2423Biol. 9: , 1989). The three classes of cell clones were characterized by distinct patterns of growth in vitro, the production of cytokines, and the presence of cytokine gene rearrangements. However, all three classes of WEHI-274 clones bore a common rearrangement of the c-myb gene, suggesting that all were derived from the one ancestral cell and that at least three distinct and independent autostimulatory events were involved in the progression of a single myeloid leukemic disease. In this article, we demonstrate that the autocrine growth factor production by the WEHI-274 leukemic clones resulted from cytokine gene activations mediated by the insertion of an intracisternal A-type particle (IAP) sequence 5' to the interleukin-3 (IL-3) gene, in the case of the class I clone, or 5' to the gene for granulocyte-macrophage colony-stimulating factor (GM-CSF), in the case of the class II clones. IAPs are defective murine retroviruses encoded by endogenous genetic elements which may undergo transpositions and act as endogenous mutagens. The functional IL-3 and GM-CSF mRNAs were generated by mechanisms in which the splice donor apparatus of the IAP sequence has been used in IAP gag-to-IL-3 or -GM-CSF splicing events.
There are numerous reports in the literature of instances in vhich the dependence of an immortal cell line on exogenous growth factors has been abrogated by autocrine or nonautocrine mechanisms, with a coincident onset of malignant behavior in vivo (27) . Experiments in which retroviral constructs directing the synthesis of interleukin-2 (IL-2), IL-3, IL-5, or granulocyte-macrophage colony-stimulating tctor (GM-CSF) have been introduced into factor-dependent hemopoietic cell lines have demonstrated elegantly that the aberrant constitutive production of a hemopoietin by an immortalized hemopoietic progenitor cell can be a critical step in myeloid leukemogenesis. The pathological, constitutive activation of growth factor genes resulting in autocrine growth in vitro has been described in a number of myeloid leukemias derived in vivo (2, 26, 27) .
Many examples can be cited in which proto-oncogenes have been pathologically activated by the insertion of retroviral sequences (4, 6, 9, 17, 18, 22, 39, 40, 42, 47, 48) . In studies of murine leukemogenesis, this mechanism of retrovirus-mediated activation of cellular genes has also been described for the pathological activation both of cytokine genes (3, 10, 44, 46, 49, 50) an; of genes encoding cytokine receptors (23, 45) . While examples of such retrovirus-mediated activations have been described for typical retroviral proviruses (44) , the vast majority of activations appear to be mediated by the transposition of intracisternal A-type particle (IAP) proviral sequences (3, 10, 44, 46, 49, 50) . IAPs are defective murine retroviruses encoded by endogenous genetic elements which are present at a copy number of about 1,000 per haploid genome of Mus musculus (7, 30) . While differing from transmissible retroviruses primarily in lacking * Corresponding author.
an extracellular phase (24, 25, 34) , nonetheless IAPs may undergo transpositions and act as endogenous mutagens.
Previously we have described the derivation of three distinct classes of leukemic cell clones from an in vivopassaged myelomonocytic leukemia, WEHI-274, that arose in a mouse infected with the Abelson leukemia virus/Moloney murine leukemia virus (MoMLV) complex (27) but in which there was no evidence of Abelson leukemia proviral insertions. The three classes of cell clones could be distinguished by their patterns of growth in vitro, the production of cytokines, and the presence of cytokine gene rearrangements. Class I comprised a single clone, bearing a rearrangement of the IL-3 gene, resulting in autocrine growth behavior in vitro mediated by IL-3. Class II comprised multiple clones, all bearing identical rearrangements of the GM-CSF gene but with no alterations in the IL-3 gene, resulting in autocrine growth behaviors mediated by GM-CSF. The cell clones of class III bore rearrangements of neither the GM-CSF nor the IL-3 gene and did not exhibit direct or indirect patterns of autocrine growth behaviors. However, a paracrine mode of growth stimulation was found to be operating bc'h in vitro and in vivo, and it appeared to be mediated by IL-lot which was constitutively released by this leukemic line and was able to stimulate the release of GM-CSF from fibroblasts and other cells (28) . Although the three classes of WEHI-274 clones were heterogeneous with respect to the production of growth factors, all clones bore a common rearrangement of the c-myb gene (27) 10-3 M), penicillin (100 U/ml), and streptomycin (100 U/ml) and with WEHI-3B-conditioned medium (2% of a 10-fold concentrate) as indicated. The cell lines WEHI-274.14 and WEHI-274.28 have been described elsewhere (27) . The murine T-cell line used was the p41.1 line described by Ziltener et al. (51) .
Genomic DNA preparation, Southern blotting, and preparation of genomic libraries. Genomic DNA was isolated according to standard methods (33) , and 7-,ug aliquots were digested with restriction endonucleases according to the recommendations of the manufacturer. Digests were separated by 0.7% agarose gel electrophoresis then blotted according to standard methods (33, 43) . In the preparation of genomic libraries from the WEHI-274.14 cell line, EcoRldigested genomic DNA was size fractionated by 0.6% agarose gel electrophoresis, and 4. The genomic IL-3 probe was a 3-kb BamHI-BamHI fragment, which included about 1.7 kb of sequence 5' to the IL-3 TATA box (courtesy of A. Dunn [37] ). The GM-CSF probe was a PstT-to-EcoRI fragment of a pUC8 subclone of GM-CSF cDNA clone 3.2 (courtesy of N. Gough [19] ). Other probes are as described in the text.
RESULTS
Rearrangement and activation of IL-3 and GM-CSi genes in distinct clones of WEHI-274. Previous studies have shown that one allele of the IL-3 gene is rearranged in the class I clone WEHI-274.14 (27) . Using an IL-3 genomic probe (a 3-kb BamHI-BamHI fragment which included exons 1 and 2 and about 1.7 kb of sequence 5' to the IL-3 coding region), Southern blot analysis of EcoRT-digested DNA from WEHI-274.14 revealed 9.1-and 5.6-kb bands in addition to the germ line 8.5-kb band. Detailed restriction endonuclease mapping using multiple genomic probes revealed that the genomic rearrangement involved the 5' end of the IL-3 gene, with the junction between rearranged and germ line DNA being less than 1,000 bp upstream of the site of the normal IL-3 coding region (27) . Northern blot analysis using whole-cell polyadenylated RNA from the class I clone (WEHI-274.14) revealed grossly abnormal IL-3 gene transcripts of 8, 4.5, and 1.3 kb (Fig. 1A) , significantly larger than the 1.1-kb RNA species from an activated T-cell clone.
Southern blot analysis of a class TI clone, WEHI-274.28, revealed a rearrangement of one allele of the GM-CSF gene but a germ line IL-3 gene (27) . This rearrangement of the GM-CSF g: ie was present and identical in all of the clones of class II. Kestriction endonuclease mapping indicated that the junction between rearranged and germ line DNA in the class II clones occurred in a region between 3.5 and 6.0 kb upstream of the GM-CSF coding region (27) . Northern blot analysis of mRNAs from the clones of class IT showed no evidence of RNA species hybridizing with an IL-3 probe (Fig. 1A) but did demonstrate grossly abnormal GM-CSF gene transcripts of 10 and 1.5-kb (Fig. 1B) seen by Northern blot analysis of T-cell-derived RNA (Fig.  1B , lane 1) are assumed to be nuclear precursors of the mature 1.3-kb GM-CSF cytoplasmic message, since the sample used included both nuclear and cytoplasmic polyadenylated RNA.
Characterization of the IL-3 gene rearrangement in WEHI-274.14. To characterize the nature of the IL-3 gene rearrangement in the class I clone (WEHI-274.14), and perhaps obtain clues as to the mechanism of generation of the abnormal IL-3 gene transcripts, lambda clones of genomic DNA were generated in parallel with experiments amplifying genomic DNA by PCR.
From a genomic library constructed from WEHI-274.14 DNA, a recombinant lambda clone (pDR) was isolated bearing a 5.6-kb insert that hybridized with an IL-3 genomic probe (3-kb BamHI-BamHl fragment including about 1.7 kb of sequence 5' to the IL-3 coding region). This 5.6-kb insert was assumed to represent the 5.6-kb EcoRI band seen on Southern blot analysis of DNA from the class I clone. Sequence analysis of the pDR clone revealed that the IL-3 gene has been disrupted by the insertion of an IAP proviral sequence ( Fig. 2) in the same transcriptional orientation as the IL-3 gene. The DNA sequence of the 5' IAP LTR (as determined from clone pDR) bore a high homology with clone pDR other IAP LTRs described in the literature (Fig. 3) . Thus, the 5.6-kb fragment comprised approximately 5.2 kb of 5' genomic IL-3 sequence and 0.4 kb of IAP sequence.
The 3' junction of the IAP proviral insertion was cloned by amplification of genomic DNA by PCR using a sense oligonucleotide primer derived from the R region of the IAP LTR (as determined from DNA sequence analysis of the 5' LTR of the IAP) and an antisense oligonucleotide primer derived from exon 5 of the IL-3 gene. The PCR-generated products were digested with HindlIl and ligated into pUC12, and the recombinant plasmid was screened with the IL-3 genomic probe. DNA sequence analysis of clone p6B4 (containing a 460-bp fragment) confirmed its derivation from the 3' junction of the IAP proviral insertion, 5' to the IL-3 coding region (Fig. 2) . DNA sequencing of this 3' LTR revealed 100% homology with the 5' IAP LTR in the R and U5 regions (data not shown).
Thus, in the WEHI-274.14 cell line, an IAP provirus has inserted 206 bp 5' to the initiator methionine codon of the IL-3 gene. The IAP sequence is flanked by a typical 4-bp inverted repeat 5'-TGTT/AACA-3', with a typical 6-bp duplication at the site of insertion (5'-GCAGTC-3') ( Fig. 2) . Using the knowledge of restriction sites predicted from the sequence analysis of clones pDR and p6B4, together with detailed restriction mapping of WEHI-274.14 genomic DNA by Southern analysis, it is evident that the inserted IAP sequence is about 6.2 kb in length (Fig. 2) .
Splicing of IAP mRNAs from germ line proviral sequences. Previous studies have shown that the abnormal 8-kb IL-3 gene transcript seen in WEHI-274.14 ( Fig. 1A ) is initiated from a site upstream of the normal IL-3 transcription initiation site (27) . Since the IL-3 gene was disrupted by the insertion of an IAP proviral sequence 5' to the gene (Fig. 2) , and since the pattern of IL-3 mRNA species seen by Northern analysis of WEHI-274.14-derived mRNAs (Fig.  1A) suggested the existence of presumed alternatively spliced forms of the IL-3-bearing transcripts, we were interested in two questions. First, do RNAs from IAP proviral sequences splice in a similar manner to that of the transcripts of retroviral proviruses? Second, is the pattern of IL U5 region  310  320  330  340  350  360  1AP274 TGCCGCA GAA GATTCTGGTC TGTGGTGTTC TTCCTGGCCG GTCGTGAGAA CGCGTCTAAT AACA answer the first of these questions, i.e., to examine the existence of splicing events in the transcripts from germ line IAP proviruses, we derived several cDNA clones encoding germ line IAP sequences.
IAP-encoding cDNA was generated by a PCR method using a single sense oligonucleotide primer derived from the R region of the IAP LTR (as determined from the pDR clone). This protocol was based on the reasoning that under conditions of low stringency, the sense primer could also function as a random antisense primer. PCR-generated cDNAs were ligated into pUC12, and clones were screened by using an IAP LTR probe (derived from pDR). DNA sequence analysis revealed that one cDNA clone (p115) contained the entire IAP gag region, thus reading through all potential RNA splice donor sites (Fig. 4A) . It was assumed that the p115 clone had derived from a genomic, unspliced IAP transcript. Sequence analysis of a further clone (p132), however, revealed a splicing event from the IAP gag region to the IAP env region (Fig. 4A and 4B) . The point at which the p132 sequence diverges from the (41) (Fig. 4A) . This splice donor site is conserved in several other published IAP sequences, including both germ line (27, 34) (Fig.  4A) . The point at which the p132 sequence becomes homologous with the env regions of published IAP sequences occurs in a region encoding a functional splice acceptor site according to the guidelines published by Shapiro and Senapathy (41) (Fig. 4B) . Similarly, this splice acceptor site is conserved in several other published germ line and transposed IAP sequences. Thus, primed with the information that IAP mRNAs do indeed undergo splicing events, we sought to investigate the mechanism underlying the generation of the abnormal IL-3 gene transcripts in the class I clone (WEHI-274.14) and the abnormal GM-CSF gene transcripts in the class II clone (WEHI-274.28).
Characterization of the abnormal IL-3 transcripts in the class I clone WEHI-274.14. On the assumption that transcription initiating 5' to a gene activated by a head-to-tail IAP insertion (i.e., an IAP provirus inserted in the same transcriptional orientation as the activated gene) most probably will initiate from one or another IAP LTR, we attempted to amplify by PCR cDNAs bearing both IAP LTR and IL-3 sequences by using nested oligonucleotide primers. The sense oligonucleotide primers were designed from a region approximately 100 bp 5' to the gag splice donor site demonstrated in Fig. 4 , while the antisense oligonucleotide primers were derived from IL-3 coding regions spanning exons 2 and 3. PCR-generated cDNAs from the two major bands (Fig. 5 , lane 2) were ligated into pUC12, and clones were screened with an IAP gag probe (derived from p115) and an IL-3 cDNA probe.
DNA sequence analysis of a double-positive clone, p1271.4, derived from the larger, approximately 400-bp PCR-generated cDNA, revealed a presumed IAP-IL-3 splicing event (Fig. 6A ). In the case of this IAP-IL-3 splicing event, the splice donor site used was the more 3' of the two potential splice donor sites demonstrated earlier (Fig. 4A ) rather than the site used in generation of the spliced mRNA from the nontransposed IAP element discussed earlier (clone p132). The splice acceptor site used is a cryptic acceptor located 24 bp 5' to the transcription initiation site of the germ line IL-3 gene (Fig. 6A) . Thus, the p1271.4 clone was derived from an mRNA, apparently initiating in the 5' LTR of an IAP inserted 5' to the IL-3 gene, which had spliced from a functional splice donor site in the IAP gag region to a cryptic splice acceptor found a short distance upstream of the IL-3 coding region (Fig. 6B) . The size of this PCR-generated cDNA is very close to the calculation of 398 bp predicted for such a spliced mRNA. Moreover, the additional 351 bases expected at the 5' end of such a spliced mRNA which has initiated from the 5' LTR of the IAP (as compared with a transcript initiating at the normal initiator of the IL-3 gene) (Fig. 6A) is in reasonable agreement with the Northern analysis of WEHI-274.14 mRNAs (Fig. 1) . In such Northern analyses (Fig. 1) , the smaller cytoplasmic IL-3 message from WEHI-274.14 was shown to be slightly larger than the normal T-cell-derived IL-3 message.
DNA sequence analysis of another double-positive clone, p1328, derived from the smaller, approximately 180-bp PCRgenerated cDNA, revealed a further IAP-IL-3 splicing event. In the case of this IAP-IL-3 splicing event, again the splice donor site used was the more 3' of the two potential splice donor sites demonstrated earlier (Fig. 4A) . However, the splice acceptor site used is the normal splice acceptor of exon 2 of the germ line IL-3 gene (Fig. 6A) . Thus, the p1328 clone was derived from an mRNA, apparently initiating in the 5' LTR of the IAP inserted 5' to the IL-3 gene, which had spliced from a functional splice donor site in the IAP gag region to the functional splice acceptor of exon 2 of the IL-3 coding region. The two additional faint bands at approximately 370 and 340 bp in Fig. 5 , lane 2 are assumed to represent rare splicing events from the IAP gag splice donor to splice acceptor consensus sequences observed at positions 696 and 737 of the published murine genomic IL-3 sequence (37) .
While the spliced mRNA represented by the p1271.4 cDNA would be expected to be productive of a functional IL-3 protein, that represented by the p1328 cDNA would not. Thus, the IAP-IL-3 splice demonstrated in the p1328 clone has resulted in (i) a coding region with no initiator methionine codon and (ii) a predicted amino acid sequence truncated of the first 29 residues of the mature IL-3 protein with no hydrophobic leader peptide.
Characterization of the abnormal GM-CSF transcripts in the class TT clone WEHI-274.28. Comparison of the Northern blot analyses of the class I and class TT clones (Fig. 1) revealed similarities in the size distribution of IL-3 mRNAs from the class I clone and GM-CSF mRNAs from the class TT clone, namely, the existence of a large dominant species of 8 or 10 kb and a less intense, smaller species of 1.3 or 1.5 kb. Experiments were devised to explore the possibility that both the abnormal IL-3 and GM-CSF gene transcripts were generated by similar IAP-mediated mechanisms.
Again, on the assumption that transcription initiating 5' to a gene activated by a head-to-tail IAP proviral insertion most probably will initiate from one or another IAP LTR, we attempted to amplify by PCR cDNAs bearing both IAP LTR and GM-CSF sequences. The from the 3' region of GM-CSF exon 4. PCR-generated cDNAs were ligated into pUC12, and clones were screened with an IAP LTR probe (derived from pDR) and a GM-CSF cDNA probe. DNA sequence analysis of a double-positive clone, clone p323a.1, revealed a presumed IAP-to-GM-CSF splicing event (Fig. 6B) . This finding suggests the strong possibility that the GM-CSF gene rearrangement observed in the class II clones (27) was indeed secondary to a head-totail insertion of an IAP provirus 5' to the GM-CSF gene.
In the case of this IAP-GM-CSF splicing event, again the splice donor site used was the more 3' of the two potential splice donor sites demonstrated earlier (Fig. 4A and 6A) . The splice acceptor site used is a cryptic acceptor located 23 bp 5' to the transcription initiation site of the germ line GM-CSF gene (Fig. 6B) . Thus, the p323a.1 clone was derived from an mRNA, presumably initiating in the 5' LTR of an IAP inserted 5' to the GM-CSF gene, which had spliced from a functional splice donor site in the IAP gag region to a cryptic splice acceptor found a short distance upstream of the GM-CSF coding region (Fig. 5B) . The size of this PCR-generated cDNA is very close to the calculation of 373 bp predicted from such a spliced mRNA, and again the additional 351 bases expected at the 5' end of such a spliced mRNA which has initiated from the 5' LTR of the IAP (as compared with a transcript initiating at the normal initiator of the GM-CSF gene) (Fig. 6B) is in reasonable agreement with the Northern analysis of WEHI-274.28 mRNAs (Fig. 1) . Thus, the smaller cytoplasmic GM-CSF message from WEHI-274.28 was shown to be slightly larger than the normal T-cell-derived GM-CSF message (Fig. 1) .
To investigate the existence of alternative IAP-to-GM-CSF splicing events, we attempted to amplify by PCR cDNAs bearing both IAP gag and GM-CSF sequences, using nested oligonucleotide primers. Again, the sense oligonucleotide primers were designed from the region approximately 100 bp 5' to the gag splice donor site demonstrated in Fig. 4 , while the antisense oligonucleotide primers were derived from GM-CSF coding regions spanning exons 2 and 3. DNA sequence analysis of the two major PCR-generated cDNAs (Fig. 5, lane 3) revealed that the larger, approximately 370-bp band was derived from the same spliced mRNA species as the p323a.1 clone, while the smaller, approximately 270-bp band was derived from a distinct IAP-to-GM-CSF spliced mRNA. This latter mRNA again utilized the more 3' of the two gag-encoded splice donor sites (Fig. 4A ) but spliced to an acceptor site in a region encoding the signal peptide of the GM-CSF protein (position 1211 of the published murine genomic GM-CSF sequence [36] ). Thus, while such an mRNA bears the full coding sequence of the mature GM-CSF protein, including a gagderived initiator methionine codon, there is no sequence encoding a hydrophobic leader peptide.
DISCUSSION
In this study, we have described the independent, pathological, IAP-mediated activations of cytokine genes (GM-CSF and IL-3) in a single in vivo-derived murine myeloid leukemia. Both rearrangements resulted in autocrine growth behaviors by the respective cells. In both cytokine gene A ml-t.mmtlmm VOL. 11, 1991 on June 30, 2017 by guest http://mcb.asm.org/ Downloaded from activations, functional mRNAs have been generated by a mechanism in which the splice donor apparatus of the IAP sequence has been used in an IAP gag-to-IL-3 or -GM-CSF splicing event.
Transposition of IAP sequences are well documented in the literature, such sequences ranging in length from isolated LTRs (10) to full-length 7.2-kb IAP proviral sequences (20) . Such examples may involve stable alterations to the germ line DNA, transmitted vertically in the context of activated (5) or disrupted and inactivated (20, 32) cellular genes. Non-germ line IAP transpositions may be detected by virtue of subsequent alterations of cell growth and neoplastic transformation. Such IAP transpositions in hematological malignancies have been described in the pathological activation of genes for IL-3 (10, 49, 50) , (46) , IL-6 (3), and GM-CSF (10, 44) and of the genes of the receptors for IL-2 (23) and . In at least two cases, more than one IAP transposition may have been involved in the progression of a single myeloid leukemia. Thus, in addition to the current study in which two distinct IAP insertions have activated the GM-CSF and the IL-3 genes in a single leukemic disease, the WEHI-3B cell line bears IAP-mediated activations of both the IL-3 gene (37, 49, 50) and the HOX-2.4 gene (4, 22) .
The transcriptional activation of IAP sequences appears to be under the control of a complex series of regulatory proteins (11) (12) (13) 31) and is influenced by such variables as DNA methylation (14, 29, 35) and the state of cellular differentiation (21) or transformation (1) . Activation of cellular genes by local insertion of IAP sequences has been postulated to be due to one of at least three general mechanisms: the introduction of a cis-acting IAP LTR enhancer either 5' (37, 49, 50) or 3' (44, 45) to the gene; the more theoretical possibility of separating the promoter of a cellular gene from 5' inhibitory sequences by the intervening insertion of an IAP sequence; and the introduction of an alternative, LTR-encoded promoter 5' to the cellular gene (9, 23, 37, 46, 49, 50) .
A new promoter may be introduced when an IAP sequence is inserted 5' to a cellular gene, irrespective of the orientation of the proviral or LTR sequences relative to the transcriptional orientation of the cellular gene. This in vitro demonstration of the bidirectionality of LTR-mediated promoter activity (8, 31) has recently been given pathological significance. Thus, the head-to-head IAP insertion into the 5' end of the c-mos coding region in the XRPC24 myeloma resulted in the transcriptional activation of that gene from a cryptic promoter in the 5' LTR of the IAP (9) . Existing reports of transcripts generated from cellular genes activated by the insertion of an IAP promoter 5' to that gene have described only two mechanisms, neither of which involves substantial RNA splicing events. First, the IAP sequence may be inserted within the coding region of the cellular gene, such that transcription will proceed directly from the LTR into exonic sequence (9) . Second, the IAP sequence may be inserted such that transcription must proceed from the LTR through sequences 5' to the cellular gene before encountering the coding region of the cellular gene. In the IAPmediated activation of the HOX-2.4 gene in WEHI-3B, it is assumed that a small sequence of nonintronic RNA has been spliced out of the IAP/HOX-2.4 transcript, based on the observation that the genomic sequence (4) differs significantly from the cDNA sequence (22 (Fig. 1A and 6A ). Similarly, the larger size of the smaller abnormal GM-CSF mRNA species (about 1.5 kb) in the class II clone WEHI-274.28 relative to that of the T-cell-derived message (about 1.3 kb) is close to the predicted size increase from the addition of the IAP-encoded LTR and gag sequences ( Fig.   1B and 5A) .
The large 8-kb IL-3 mRNA species observed on Northern analysis of WEHI-274.14 (class I) mRNAs (Fig. 1A) (27) . Similarly, the large 10-kb GM-CSF mRNA species observed on Northern analysis of WEHI-274. 28 (class II) mRNAs (Fig. IB) probably represents the analogous primary IAP-to-GM-CSF read-through transcript. On Northern analysis of IL-3 mRNAs from WEHI-274.14 ( Fig.  1A) , in addition to the fully spliced 1.3-kb transcript and the 8-kb partially spliced read-through transcript, a 4.5-kb species is evident. The size of this 4.5-kb transcript is consistent with it representing a spliced product of the 8-kb transcript truncated by the gag-to-env splicing event demonstrated in this study for mRNAs from germ line IAP proviral sequences (Fig. 4) . We are currently exploring this possibility.
A similar phenomenon of transcriptional read-through from an inserted proviral sequence into a 3' gene has been described in the case of a B2m gene rearranged by the insertion of an Abelson murine leukemia proviral sequence into intron 1 of that gene (16) . In that study, Northern blot analysis revealed a large mRNA species presumed to be the unspliced (or partially spliced) read-through transcript, which gave rise to a smaller, spliced mRNA. Thus, while we are not aware of any examples in the literature of splicing events from IAP to cellular sequences in the generation of functional cytokine or other mRNAs, certainly such a mechanism is not without precedent for retrovirus-mediated gene activations (18, 38, 42, 47 (47) , analysis of transcripts of a c-Ki-ras gene, rearranged by the 5' insertion of Friend proviral DNA, again revealed a chimeric mRNA species processed by a splicing event associated with the fortuitous creation of a cryptic splice donor site at the junction between the proviral and cellular DNA sequences. Analogous to the situation in the current study, the splice acceptor site is a cryptic site lying just 5' to exon one of the c-Ki-ras gene, giving rise to a presumably normal translation product. However, save the B2m gene rearrangement (16) , in none of these examples are chimeric mRNAs produced by subjugation of the normal splice donor apparatus of the retrovirus as has been demonstrated in the current study.
While functional cellular gene transcripts may arise from RNA processing of primary transcripts with splicing from 5' retrovirus to 3' cellular gene, the converse may occur when a cellular gene has been activated by the insertional of a retroviral enhancer 3' to the cellular gene (38) . In such situations, chimeric mRNAs can be demonstrated which have been processed by a splicing event from a normal splice donor of the activated cellular gene, to a splice acceptor in the 3' retroviral sequence.
From this and earlier studies, it is evident that a significant number of potentially transforming genetic lesions in murine hematological malignancies are due to IAP transposition with resultant pathological gene activations. While there is little evidence for a role for endogenous transposable elements in human neoplasias, analysis of the molecular mechanisms of IAP-mediated murine gene activations will continue to provide insights into the myriad mechanisms through which retroviruses contribute to pathology in specific mammalian and avian diseases.
